May 10 is "China Brand Day". On May 10, 2017, the State Council set up the "China Brand Day", aiming to promote the construction of a quality power, so that the world can hear the voice of Chinese enterprises and see the creation of Chinese enterprises. On the same day, for the people of Shouxian Valley, there is another "special significance" worth remembering.
On May 10, 2017, Shouxian Valley, a time-honored Chinese brand committed to "building the first brand of organic Chinese medicine", successfully landed on the A-share main board of the Shanghai Stock Exchange (stock code: 603896), becoming the first stock in China's Ganoderma lucidum and Dendrobium officinale industry, and also opened a new journey of high-quality development of Shouxian Valley.
Scientific and technological innovation revitalizes Sinopharm
The background color of the high-quality development of Shouxian Valley
As the undertaking unit of the international standard formulation of "Traditional Chinese Medicine - Ganoderma lucidum", Shouxian Valley has been deeply engaged in the research and development and clinical research of Ganoderma lucidum and Ganoderma lucidum spore powder related products. The content of active ingredients is 10 times higher than that of ordinary broken wall Ganoderma lucidum spore powder, which solves the problems of mixed ineffective wall shell components and active ingredients of broken wall Ganoderma lucidum spore powder, and unsatisfactory medicinal effect, which is recognized by the market and welcomed and loved by consumers.
Since its listing, Shouxian Valley has taken the academician expert workstation as the core, and four academicians led by Sun Yan, Zhang Boli, Li Yu and Huang Luqi have established a scientific and technological innovation platform based on "one room, one station, two alliances, two academies and seven centers"; Strengthen multidisciplinary joint research, and carry out in-depth cooperation with many top scientific research institutions at home and abroad, such as Peking University, Zhejiang University, Tianjin University of Traditional Chinese Medicine, France-Europe Precision Medicine Platform, and Mayo Clinic in the United States, to carry out pharmacological and clinical trial research on the pharmacological efficacy and clinical trials of Ganoderma lucidum spore powder to enhance immunity, anti-tumor, and improve cardiovascular diseases; Cooperate with Academician Zhang Boli to build a smart health innovation laboratory to create a "artificial intelligence + medicine and health" scientific and technological innovation platform; Jointly established the Shouxian Valley Biological Breeding Innovation Center with the team of Academician Li Yu of Jilin Agricultural University to carry out research on the breeding of new varieties and cooperation in pharmacology and efficacy research; In response to the homology of Ganoderma lucidum and Dendrobium officinale with medicine and food, the Shouxian Valley Functional Food and Nutrition and Health Research Institute was established to jointly carry out the development of a series of big health products with the same origin of medicine and food, and continuously consolidate scientific and technological innovation, the core guarantee for the development of enterprises.
Academician Chen Shilin, Academician Xie Mingyong, Academician Zhu Beiwei, Academician Chen Jian, Academician Yu Jingquan
After years of industry-university-research cooperation, Shouxian Valley has become a typical case of small and medium-sized enterprises in mainland China relying on technological innovation and standard innovation to lead the development and growth, technology patenting, patent standardization and standard internationalization. In recent years, the company has won major awards such as "Zhejiang Provincial People's Government Quality Award", "National Key Agricultural Leading Enterprise" and "Zhejiang Science and Technology Progress Award".
In addition, as the leading unit of international standards for traditional Chinese medicine-Ganoderma lucidum and traditional Chinese medicine-Dendrobium officinale, the "Ganoderma lucidum spore powder and particle wall removal technology" developed by Shouxian Valley was officially awarded the US invention patent certificate (patent number: US 11,633,444 B2), which is another scientific and technological patent achievement of great significance in the international field after obtaining the Japanese invention patent certificate in 2021.
Break through the self and transform the wisdom of the mind
A century-old brand injects new vitality into the brand
As a time-honored intangible cultural heritage brand with a history of 115 years, Shouxian Valley can not only keep the classics, but also become an Internet celebrity. Since its listing, it has planned to enter the embassies of various countries, appeared at the Shanghai International Import Expo, or became the official Ganoderma lucidum product supplier of the Hangzhou Asian Games, and exclusively named the Zhejiang Provincial Swimming Team to help Chinese mountaineers climb Mount Everest...... Behind all this is a traditional time-honored brand actively seeking innovation, breaking through itself, and embracing the transformation of young customers.
In recent years, Shouxian Valley has also held the "Ganoderma lucidum Cultural Festival" as the carrier, through the form of pop-up stores in the major business districts and partner channel platforms in Zhejiang Province, and Hangzhou Mansion co-branded limited national tide health coffee, in the form of a trend to open the immersive experience of Ganoderma lucidum culture, attracting a group of new and old consumers to visit the store and check in, with young people like to see the trendy way and cross-border operation, to promote the traditional Chinese medicine industry into the young customer group, so as to open up a broader market for Shouxian Valley.
In addition, Shouxian Valley has also actively carried out poverty alleviation, poverty alleviation, disaster relief, elderly assistance, student assistance, and helping farmers get rich through science and technology through the form of public welfare, set up the "Shouxian Valley Fraternity Fund", and carried out activities such as "Caring for Oncology Students", "Fulfilling Your College Dream", and establishing "Shouxian Valley Wuyi No. 1 Middle School Scholarship" for 7 consecutive years, unswervingly giving back to the society in the best way possible, demonstrating the brand responsibility of a Chinese pharmaceutical company of "valuing morality and sincerity".
During the new crown epidemic, in the face of the sudden epidemic, Shouxian Valley acted quickly to donate more than 14 million yuan for the front-line medical and prevention and control workers in the fight against the epidemic, for the resumption of work and production for enterprises, and to help overseas Chinese alleviate the tension of material shortages, which was widely praised by all sectors of society.
In the past 7 years since its listing, Shouxian Valley has actively fulfilled its responsibilities and donated more than 35 million yuan in cash and materials to the society. With these social contributions, Shouxian Valley has won the "Zhejiang Charity Award" and the "China Red Cross Dedication Medal" issued by the Zhejiang Provincial Government, which has attracted more and more attention and recognition from the public.
At present, Shouxian Valley is comprehensively building a system for the high-quality development of the whole industrial chain of traditional Chinese medicine with "Internet + big health, big platform, big data, and big service", empowering the intelligence and standardization of the whole industrial chain of Shouxian Valley with digital integration and in-depth promotion, and building "future farm + future factory + future market", maximizing and ensuring product quality through standardization, intelligence and digitalization, promoting the sustainable development of the enterprise, and better assuming the responsibilities and missions entrusted by the times. Continuously contribute to the development of traditional Chinese medicine in the motherland.